Bozhedomov V.A.
Department of Clinical Andrology, FATHCW of Medical Institute, Peoples Friendship University of Russia.
Department of Obstetrics, Gynecology, Perinatology and Reproductology, IPEP, I.M. Sechenov First MSMU, Moscow.
Chronic prostatitis: a new paradigm of treatment
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 3 Suppl 3 С. 78-90
2016
antibiotic therapy
chronic pelvic pain syndrome
chronic prostatitis
lower urinary tract symptoms
prostatic pain syndrome
Статья
Обзор
Adrenergic alpha-Antagonists therapeutic use D27.505.519.625.050.200.100 D27.505.696.577.050.200.100
Адренергические альфа-антагонисты терапевтическое применение D27.505.519.625.050.200.100 D27.505.696.577.050.200.100
Anti-Bacterial Agents therapeutic use D27.505.954.122.085
Антибактериальные средства терапевтическое применение D27.505.954.122.085
Chronic Disease C23.550.291.500
Хроническая болезнь C23.550.291.500
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Male
Мужской
Physical Therapy Modalities E02.779 E02.831.535
Физиотерапии методы E02.779 E02.831.535
Practice Guidelines as Topic N04.761.700.350.650 N05.700.350.650
Руководящие указания для практического здравоохранения как тема N04.761.700.350.650 N05.700.350.650
Prostatitis etiology C12.100.500.565.750 C12.200.294.565.750
Prostatitis physiopathology C12.100.500.565.750 C12.200.294.565.750
Prostatitis therapy C12.100.500.565.750 C12.200.294.565.750
Простатит этиология C12.100.500.565.750 C12.200.294.565.750
Простатит патофизиология C12.100.500.565.750 C12.200.294.565.750
Простатит терапия C12.100.500.565.750 C12.200.294.565.750
Treatment Outcome E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
Лечения результатов анализ E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
Journal Article V02.600
Журнальная статья V02.600
Review V02.600.500 V02.912
Обзор V02.600.500 V02.912
This paper proposes health care recommendations for men with chronic prostatitis (CP) taking into account etiopathogenesis and the clinical presentation of the disease. The proposal is based on the experience of federal and regional clinics of urology and gynecology, respective departments for postgraduate education and on the analysis of scientific literature. It is shown that managing patients with CP requires consideration of factors beyond the traditional practice of urology. The author validates the need to use the modern prostatitis classification UPOINT instead of the traditional NIH NIDDK (1995) to increase the effectiveness of treatment. It is demonstrated that the concurrent use of medications and non-pharmacological treatments aimed at different aspects of the state improve the treatment effectiveness. Indications are refined for medical and non-pharmacological treatments: antibiotics, alpha-blockers, anticholinergic agents, analgesics, antidepressants, herbal remedies, pelvic floor physiotherapy, psychotherapy. The shortcomings and mistakes of existing guidelines/standards are analyzed.